Caprelsa
Generic: vandetanib
Manufacturer: Sanofi Genzyme · Program: CAPRELSA Patient Assistance Program
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured or have a plan that does not cover CAPRELSA
Residency
US resident
Uninsured or underinsured; Medicare Part D may qualify
Program Information
Processing Time
2–8 weeks
Delivery Method
shipped to patient
Application Method
Phone
Reauthorization
Required — Patient must contact program
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- proof of residency
- proof of income
- prescription
Indicated For
medullary thyroid cancer
About This Medication
# CAPRELSA Patient Assistance Program Patient Guide: How to Get CAPRELSA at Low or No Cost CAPRELSA (vandetanib) is a prescription medication used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. The **CAPRELSA Patient Assistance Program**, offered by **Sanofi Genzyme**, provides the drug **free of charge** to eligible uninsured or underinsured patients whose insurance does not cover CAPRELSA.[1][2][8] ## About CAPRELSA **CAPRELSA** is a kinase inhibitor that works by interfering with cell communication signals, which may prevent tumor growth in medullary thyroid cancer (MTC). It is specifically indicated for adults with unresectable locally advanced or metastatic MTC that is symptomatic or progressive. Clinical data from the ZETA study showed CAPRELSA reduced the risk of disease progression by 65% compared to placebo, extending progression-free survival, though it did not improve overall survival.[9] **Important safety note**: CAPRELSA is only available through the restricted **CAPRELSA REMS Program** due to risks like QT prolongation, which can cause irregular heartbeats. Contact your doctor immediately if you feel faint, light-headed, or notice heart irregularities. For REMS info, call 1-800-817-2722.[1][2] Common side effects may affect normal cells too, so regular monitoring (ECG, electrolytes, TSH) is required at baseline and periodically.[3][4] ## Who Qualifies for the Program? The program targets patients who **medically need CAPRELSA** as prescribed by their physician and meet these criteria: - **Uninsured** or **underinsured** (insurance plan does not cover CAPRELSA). - **Medicare Part D patients may qualify** if their plan lacks coverage.[1][8] - U.S. residents (including Puerto Rico).[8] - **Needs-based**: Proof of financial need is required; no strict Federal Poverty Level (FPL) thresholds listed, but program assesses income and situation individually.[1][8] **Note**: This is separate from the CAPRELSA Co-Pay Program (for commercial insurance with high out-of-pocket costs >$50) or Interim Access Program (short-term supply for barriers like prior authorizations).[1][2] ## Income Eligibility Breakdown Specific income thresholds (e.g., % of FPL) are not publicly detailed; eligibility is determined case-by-case based on proof of income, residency, and insurance status. Medicare patients without CAPRELSA coverage often qualify. Contact the program for personalized assessment.[1][8] | Household Size | Income Threshold | Notes | |---------------|------------------|-------| | Individual | Not specified | Assessed individually; uninsured/underinsured prioritized. | | Couple | Not specified | Proof of income required. | | Family of 3 | Not specified | Medicare Part D may qualify if no coverage. | | Family of 4+ | Not specified | Call for details: (800) 367-4999. | [Table based on provided program data; always verify with program as guidelines may update.][1][8] ## Insurance Requirements - **Uninsured** or **have a plan that does not cover CAPRELSA** (inadequate coverage).[1][2][8] - Commercially insured patients should explore the Co-Pay Program instead.[1] - **Medicare**: Part D enrollees may qualify for free drug if denied coverage.[1][8] - The **CAPRELSA Access Support** team via Biologics, Inc., helps verify benefits and prior authorizations.[2][4] ## Step-by-Step Application Process 1. **Confirm eligibility**: Discuss with your doctor if CAPRELSA is right for you and REMS enrollment.[1] 2. **Gather documents**: - **Proof of residency** (e.g., utility bill, driver's license). - **Proof of income** (e.g., tax returns, pay stubs, SSI/SSDI letters). - **Prescription** from your physician.[1][8] 3. **Call to apply**: Contact **CAPRELSA Access Support Program** at **(800) 367-4999**. Applications are by **phone** only; no online form listed.[1][2][8] 4. **Physician involvement**: Your doctor must complete parts of the application.[8] 5. **Submit**: Program coordinates with Biologics pharmacy; fax forms if needed (e.g., 1-888-275-8593).[8] 6. **Approval**: If approved, medication ships **directly to you** free of charge.[1][8] **Reauthorization required**: Periodic renewal needed to continue supply.[Provided data] ## Timeline and Delivery - **Processing time**: Not specified; call for updates. Biologics team provides refill reminders and 24/7 pharmacist support.[2] - **Delivery**: Shipped free to your home via specialty pharmacy (Biologics, Inc.).[1][2] - Expect contact from pharmacy team post-approval for onboarding, benefit checks, and ongoing support.[2][4] ## Alternatives if Denied - **CAPRELSA Co-Pay Program**: For commercial insurance; up to program max if out-of-pocket >$50/year.[1] - **Interim Access Program**: Short-term free supply for insurance barriers (e.g., PA delays).[1][2] - **Sanofi Patient Connection**: Broader Sanofi assistance for eligible meds.[5] - **General resources**: RxAssist.org, NeedyMeds, or state programs. No biosimilars available.[7] - Appeal denial or reapply with updated docs; call (800) 367-4999.[1] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and availability can change; **always contact the program directly at (800) 367-4999** for the latest details. Not a substitute for medical advice—consult your healthcare provider. Sanofi Genzyme and CAPRELSA Access Support reserve rights to modify or end the program. Participation does not guarantee approval.[1][2][8]
Program information last verified: March 30, 2026
Ready to apply for Caprelsa assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.